Cardiatis MFM® products have CE-mark approval for Complex Aortic Aneurysms and peripheral artery aneurysms, and CE-mark approval is pending for the Cardiatis Intracranial device and Bifurcated device kit.

Cardiatis relies on a network of strong partners in various countries to market and promote its products. Do not hesitate to contact our sales team to obtain more information on our products.

Peripheral and Aortic Multilayer Flow Modulator (MFM®) devices are available in the countries displayed below.

  • Argentina
  • Brazil
  • Colombia
  • European countries
  • India
  • Israël
  • Morocco
  • Singapore
  • Saudi Arabia
  • South Korea
  • Sri Lanka
  • Thaïland
  • Turkey
  • Venezuela